Advancements in Bioprocess Engineering and Plasma

2024

Closed access Metadata (CSL-JSON)
DOI 10.4018/979-8-3693-0904-9.ch012
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Bioprocess engineering and plasma technology have ushered in a new era of medicine production, transforming the pharmaceutical industry, and improving healthcare outcomes. This chapter explores the latest advancements in these fields and their significant impact on revolutionizing medicine production. The authors delve into key developments in bioprocess engineering, such as genome editing techniques, high-throughput screening, continuous bioprocessing, and synthetic biology. Additionally, the authors examine the diverse applications of plasma technology, including sterilization, plasma-enhanced chemical vapour deposition, disinfection of biological fluids, and plasma activation of surfaces. Together, these innovative approaches have accelerated drug development, enhanced drug delivery systems, and paved the way for personalized medicine.